Back to Results
First PageMeta Content
Panitumumab / Amgen / Chemotherapy / Docetaxel / Stomach cancer / Oncology / Cetuximab


ATTAX3: Panitumumab added to docetaxel, cisplatin, fluoropyrimidine in oesophagogastric cancer The ATTAX3 trial has helped researchers answer an important health question. It has provided evidence on the value of a new c
Add to Reading List

Document Date: 2016-02-25 18:33:39


Open Document

File Size: 298,23 KB

Share Result on Facebook